Global Leukemia Therapeutics Industry Size to hit USD 8.82 Bn by 2021

Posted by rohan on October 11th, 2017

According to the report Global Leukemia Therapeutics Industry, published by Market Data Forecast, The industry has been estimated at USD 5.60 Billion in 2016 and is projected to reach USD 8.82 Billion by 2021, at a CAGR of 9.5% during the forecast period from 2016 to 2021.

Leukemia is a type of blood cancer which results in abnormal production of leukocytes or WBC. They crowd the bone marrow and other organs such as liver, spleen, and kidneys through blood and prevent its normal functions. The disease is commonly caused due to the high exposure to radiations, unhealthy lifestyle, genetic factors, and environmental conditions.

Browse industry data tables and in-depth TOC of the Global Leukemia Therapeutics Industry to 2021 @

The industry for Leukemia Therapeutics globally is driven mainly due increasing aging population which is resulting in increasing prevalence of leukemia, as the disease occurrence is mainly seen in middle-aged people and senior citizens. Also, with recent breakthroughs in this area by Research teams across the globe, the scope for treatments is also widening. But, high treatment costs and drug costs are the issues hindering the growth of the industry.

Global industry for Leukemia Therapeutics is segmented based on disease condition, diagnosis, treatments and drugs. By disease condition, the industry is further sub-segmented into chronic lymphatic leukemia, acute lymphatic leukemia, chronic myeloid leukemia and acute myeloid leukemia. By diagnosis, the industry is further sub-segmented into CT scan, biopsy and MRI. By treatments, the industry is further sub-segmented into chemotherapy, radiation therapy, immunotherapy, surgery, targeted therapy, bone marrow transplant and stem cell therapy. By drugs, the industry is further sub-segmented into Gleevec, Sapacitabine, GA101, Vasaroxine, Tosedosat. By disease condition, chronic myeloid leukemia dominated the overall therapeutic industry owing to high prevalence rate. Stem cell therapy and bone marrow transplant are the emerging trends in leukemia therapeutic industry. Gleevec was one of the major industry growth contributors, in the drugs category.

Free sample of the report is available @

Geographically, Global industry for Leukemia Therapeutics is segmented into North America, Asia Pacific, Latin America, Europe, and Africa & Middle-East. North America holds the largest share of the global industry, followed by Europe. Factors such as rising prevalence of cervical cancer, growing awareness of cervical cancer screening programs, and government support are driving the growth of the Leukemia therapeutics industry in the North American region. Asia Pacific industry is growing at very high rate, due to rising consumer industry, increasing aging population, and rising awareness for healthcare among the population in developing nations of the region.

Hoffmann-La Roche Ltd , GlaxoSmithKline Pharmaceuticals Limited , Novartis International AG, Bristol-Myers Squibb , Eisai Co. Ltd, Biogen Idec , ERYtech Pharma , Celgene Corporation, Genmab A/S, Cephalon Inc., Clavis Pharma, and Pfizer Inc. are the major players of Global Leukemia Therapeutics industry.

Key Points from Table of Contents


  • Executive Summary
  • Key Inferences
  • New Developments

Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

Industry: Segmentation

  • By Disease Condition
    • Chronic Lymphatic Leukemia
    • Acute Lymphatic Leukemia
    • Chronic Myeloid Leukemia
    • Acute Myeloid Leukemia
  • By Diagnosis
    • CT scan
    • Biopsy
    • MRI
  • By Treatments
    • Chemotherapy
    • Radiation therapy
    • Immunotherapy
    • Surgery
    • Targeted Therapy
    • Bone marrow transplant
    • Stem Cell Therapy
  • By Drugs
    • Gleevec
    • Sapacitabine
    • GA101
    • Vasaroxine
    • Tosedosat

Geographical Analysis

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

Strategic Analysis

  • PESTLE analysis
  • Porter’s Five analysis

Industry Leaders' Analysis

Competitive Landscape

About Us:

Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.


Abhishek Shukla

Sales Manager (International Business Development)

Market Data Forecast

Direct Line: +1-888-702-9626

Mobile: +91 998 555 0206



Like it? Share it!


About the Author

Joined: September 20th, 2017
Articles Posted: 1,346

More by this author